Tags

Type your tag names separated by a space and hit enter

[The effects of somatostatin in acromegaly].
Nouv Presse Med. 1976 Mar 06; 5(10):629-32.NP

Abstract

Somatostatine is the hypothalamic factor which inhibits the secretion of growth hormone. The administration of a synthetic form decreased growth hormone levels by 50 to 75% in 5 acromegalic patients. The action is rapid but the effect is not prolonged. Prolactin was reduced in only case with galactorrhea. Thyreostimulin, as well as gastrin, are unaffected. Plasma insulin levels, and to a lesser extent those of glucagon, are decreased by somatostatine which causes no variation in either cortisol or blood glucose. Somatostatine, by correcting the pathological secretion of hormone, opens the way to medical treatment of acromegaly.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
English Abstract
Journal Article

Language

fre

PubMed ID

772591

Citation

Schaison, G, et al. "[The Effects of Somatostatin in Acromegaly]." La Nouvelle Presse Medicale, vol. 5, no. 10, 1976, pp. 629-32.
Schaison G, Roger M, Milhaud G. [The effects of somatostatin in acromegaly]. Nouv Presse Med. 1976;5(10):629-32.
Schaison, G., Roger, M., & Milhaud, G. (1976). [The effects of somatostatin in acromegaly]. La Nouvelle Presse Medicale, 5(10), 629-32.
Schaison G, Roger M, Milhaud G. [The Effects of Somatostatin in Acromegaly]. Nouv Presse Med. 1976 Mar 6;5(10):629-32. PubMed PMID: 772591.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [The effects of somatostatin in acromegaly]. AU - Schaison,G, AU - Roger,M, AU - Milhaud,G, PY - 1976/3/6/pubmed PY - 1976/3/6/medline PY - 1976/3/6/entrez SP - 629 EP - 32 JF - La Nouvelle presse medicale JO - Nouv Presse Med VL - 5 IS - 10 N2 - Somatostatine is the hypothalamic factor which inhibits the secretion of growth hormone. The administration of a synthetic form decreased growth hormone levels by 50 to 75% in 5 acromegalic patients. The action is rapid but the effect is not prolonged. Prolactin was reduced in only case with galactorrhea. Thyreostimulin, as well as gastrin, are unaffected. Plasma insulin levels, and to a lesser extent those of glucagon, are decreased by somatostatine which causes no variation in either cortisol or blood glucose. Somatostatine, by correcting the pathological secretion of hormone, opens the way to medical treatment of acromegaly. SN - 0301-1518 UR - https://www.unboundmedicine.com/medline/citation/772591/[The_effects_of_somatostatin_in_acromegaly]_ L2 - https://www.diseaseinfosearch.org/result/162 DB - PRIME DP - Unbound Medicine ER -